Clinical TREAT Antifungal Powder, Vanilla Scent, 3 OZ (85 g) tube, Active Ingredient: Miconazole ...

FDA Drug Recall #D-0091-2024 - Class II, October 4, 2023

Recall Summary

Recall Number D-0091-2024
Classification Class II - Moderate risk
Date Initiated October 4, 2023
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm MEDLINE INDUSTRIES, LP - Northfield
Location Northfield, IL
Product Type Drugs

Product Description

Clinical TREAT Antifungal Powder, Vanilla Scent, 3 OZ (85 g) tube, Active Ingredient: Miconazole Nitrate 2.0% w/w Antifungal, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093 USA, NDC: 53329-169-79

Reason for Recall

CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation for low assay results on the active ingredient miconazole nitrate.

Distribution Pattern

Nationwide

Lot / Code Information

Lot 007782, Exp 08/31/2024

Other Recalls from MEDLINE INDUSTRIES, LP - Northfield

Recall # Classification Product Date
D-0604-2025 Class II Good Neighbor Pharmacy, Alcohol Prep Pads, Dist... Jul 7, 2025
D-0601-2025 Class II CURAD Alcohol Prep Pads, Sterile, Medium, 2-Ply... Jul 7, 2025
D-0602-2025 Class II ReliOn, Sterile Alcohol Swabs, Skin Cleanser, 2... Jul 7, 2025
D-0600-2025 Class II Medline Alcohol Prep Pads, 70% Isopropyl Alcoho... Jul 7, 2025
D-0605-2025 Class II RITE AID PHARMACY, first aid alcohol prep pads,... Jul 7, 2025

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice, the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful, in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.